Clinical Trials
10 trialsNCT06284226 2024-04-16
CCT-ANK-11
Beijing Kejing Biotechnology Co., Ltd.
Phase EARLY_PHASE1 Withdrawn
NCT05238831 2024-01-23
SMMART Adaptive Clinical Treatment (ACT) Trial
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Withdrawn
NCT04870034 2023-12-22
Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer
Roswell Park Cancer Institute
Phase EARLY_PHASE1 Withdrawn
NCT05465590 2023-12-21
A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer
Mainline Biosciences, Inc.
Phase EARLY_PHASE1 Withdrawn
NCT01371240 2022-06-16
Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor Conspicuity
University Hospitals Cleveland Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT04123574 2022-02-24
A Pilot Study of BXCL701 in Patients With Pancreatic Cancer
BioXcel Therapeutics Inc
Phase EARLY_PHASE1 Withdrawn
NCT03536208 2021-03-25
Biological Effect of Warfarin on Pancreatic Cancer
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT03718650 2021-02-08
Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Withdrawn
NCT02442739 2018-11-06
Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT01694589 2014-12-12
A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer
Rutgers, The State University of New Jersey
Phase EARLY_PHASE1 Withdrawn